|
ALG13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.524700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.756500E-02 |
| Normal-vs-Stage2 |
6.331400E-01 |
| Normal-vs-Stage3 |
8.988000E-04 |
| Normal-vs-Stage4 |
3.707600E-02 |
| Stage1-vs-Stage2 |
4.947600E-01 |
| Stage1-vs-Stage3 |
8.173800E-02 |
| Stage1-vs-Stage4 |
3.919000E-01 |
| Stage2-vs-Stage3 |
8.552400E-02 |
| Stage2-vs-Stage4 |
2.777200E-01 |
| Stage3-vs-Stage4 |
5.957200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.815500E-03 |
| Normal-vs-AfricanAmerican |
7.494000E-02 |
| Normal-vs-Asian |
1.540080E-02 |
| Caucasian-vs-AfricanAmerican |
9.264600E-01 |
| Caucasian-vs-Asian |
4.893600E-01 |
| AfricanAmerican-vs-Asian |
4.599000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.442200E-04 |
| Normal-vs-Female |
1.480390E-01 |
| Male-vs-Female |
1.503440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.40259999999548E-05 |
| Normal-vs-Age(41-60Yrs) |
9.692200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.403460E-03 |
| Normal-vs-Age(81-100Yrs) |
7.876600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.758400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.840100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.516000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.636830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.913000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.102000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.545200E-01 |
| Normal-vs-Grade 2 |
2.846000E-01 |
| Normal-vs-Grade 3 |
2.995500E-04 |
| Normal-vs-Grade 4 |
4.56220000000229E-06 |
| Grade 1-vs-Grade 2 |
4.427600E-01 |
| Grade 1-vs-Grade 3 |
6.820100E-02 |
| Grade 1-vs-Grade 4 |
1.175750E-02 |
| Grade 2-vs-Grade 3 |
3.084400E-02 |
| Grade 2-vs-Grade 4 |
7.203700E-04 |
| Grade 3-vs-Grade 4 |
7.023800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.907430E-01 |
| Normal-vs-ccB subtype |
1.422020E-03 |
| ccA subtype-vs-ccB subtype |
3.452400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.659500E-02 |
| Normal-vs-N1 |
3.122400E-03 |
| N0-vs-N1 |
6.042300E-02 |
|
|
